(Q33253913)

24 July 2017

Downregulation of RUNX3 and TES by hypermethylation in glioblastoma (English)

1 reference

24 July 2017

1 reference

1 reference

W Mueller

1

1 reference

24 July 2017

C L Nutt

2

1 reference

24 July 2017

M Ehrich

3

1 reference

24 July 2017

M J Riemenschneider

4

1 reference

24 July 2017

A von Deimling

5

1 reference

24 July 2017

D van den Boom

6

1 reference

24 July 2017

D N Louis

7

1 reference

24 July 2017

language of work or name

English

0 references

publication date

14 August 2006

1 reference

24 July 2017

1 reference

24 July 2017

26

1 reference

24 July 2017

583-593

1 reference

24 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209805

24 July 2017

0 references

cites work

Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

TP53 Gene Mutations and 17p Deletions in Human Astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Aberrant methylation of genes in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Restriction landmark genome scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Frequent epigenetic inactivation of the SLIT2 gene in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Aberrant DNA methylation as a cancer-inducing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Role for DNA methylation in the control of cell type specific maspin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Genetic markers in glioblastoma: prognostic significance and future therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Epigenetics: The Role of Methylation in the Mechanism of Action of Tumor Suppressor Genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Methylation and silencing of the Thrombospondin-1 promoter in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Concordant methylation of the ER and N33 genes in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

DNA methylation differences associated with tumor tissues identified by genome scanning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Functional epigenomics identifies genes frequently silenced in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Molecular pathology of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Levels of DNA methylation in diploid and SV40 transformed human fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

High-throughput MALDI-TOF discovery of genomic sequence polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

Epigenetic silencing of maspin gene expression in human breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

The retinoblastoma gene is involved in malignant progression of astrocytomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

Astrocytic gliomas: characterization on a molecular genetic basis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

Methylation of the p73 gene in gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209805

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209805

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference